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F o r P e e r R e v i e w
We evaluated the Hain GenoQuick® (GQM) methicillin resistant Staphylococcus aureus (MRSA) assay for the rapid detection of MRSA using one swab, i.e. the same screening specimen was used first for MRSA culture and then for rapid testing by PCR, as this would be the preferred option for routine diagnostic testing. GQM detected current prevalent Irish MRSA strains incorporating all known SSCmec types including Panton-Valentine leukocidin positive strains. All methicillin resistant coagulase negative staphylococci tested were negative but three of seven gentamicin-resistant MSSA strains tested were identified as MRSA by the GQM method. The theoretical ex-vivo limit of detection of the assay was 704 colony forming units (CFU) per GQM assay reaction (1.7x104CFU/ml) when MRSA suspensions were used for DNA extraction or 1.4x103 CFU/swab (1.4x104 CFU/ml) using MRSA absorbed onto Copan screening swabs. We demonstrated that swab processing on chromogenic agar prior to PCR resulted in some inhibition of the PCR reaction, increasing the limit of detection of the assay by a factor of 4. Based on the processing of 540 screening specimens (nasal and groin) by culture first and GQM second, the specificity and positive predictive value were both 100%, the negative predictive value was 92%, and the sensitivity was 57%. Culture followed by PCR from one specimen is not optimal for the rapid detection of MRSA. Further laboratory validation of the GQM assay is required to determine the true diagnostic sensitivity and value of this kit in routine microbiology laboratories, either with PCR before culture or using two specimens. We evaluated the Hain GenoQuick® (GQM) methicillin resistant Staphylococcus 25 aureus (MRSA) assay for the rapid detection of MRSA using one swab, i.e. the same 26 screening specimen was used first for MRSA culture and then for rapid testing by PCR, 27 as this would be the preferred option for routine diagnostic testing. GQM detected current 28 prevalent Irish MRSA strains incorporating all known SSCmec types including Valentine leukocidin positive strains. All methicillin resistant coagulase negative 30 staphylococci tested were negative but three of seven gentamicin-resistant MSSA strains 31 tested were identified as MRSA by the GQM method. 32
The theoretical ex-vivo limit of detection of the assay was 704 colony forming 33 units (CFU) per GQM assay reaction (1.7x10 4 CFU/ml) when MRSA suspensions were 34 used for DNA extraction or 1.4x10 3 CFU/swab (1.4x10 4 CFU/ml) using MRSA absorbed 35 onto Copan screening swabs. We demonstrated that swab processing on chromogenic 36 agar prior to PCR resulted in some inhibition of the PCR reaction, increasing the limit of 37 detection of the assay by a factor of 4. Based on the processing of 540 screening 38 specimens (nasal and groin) by culture first and GQM second, the specificity and positive 39 predictive value were both 100%, the negative predictive value was 92%, and the 40 sensitivity was 57%. Culture followed by PCR from one specimen is not optimal for the 41 rapid detection of MRSA. Further laboratory validation of the GQM assay is required to 42 determine the true diagnostic sensitivity and value of this kit in routine microbiology 43 laboratories, either with PCR before culture or using two specimens. 44 45 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 only with a reported turn around time of approximately two and a half hours. MRSA 59 specific chromosomal sequences are targeted. The assay consists of three steps: direct 60 DNA extraction from a patient swab using a lysis buffer provided, followed by multiplex 61 PCR (primer/probe/nucleotide mix provided) with single stranded amplicon hybridization 62 using a specific probe and finally, the detection of amplicon/probe complex -the complex 63 selectively binds to the test band on the dipstick and is visualized by gold labeling. Each 64 dipstick includes two control zones, a conjugate control zone to check the binding of the 65 conjugate on the dipstick and an amplification control zone to check for a successful 66 amplification reaction. 67
Here we determined the accuracy and the limit of detection (LoD) of the GQM 68 assay and established the potential to use one MRSA screening swab for two methods of 69 
Limit of detection (LoD) assays 102
LoD assays (n=3) of the GQM assay were performed as follows: A 0.5 M c Farland 103 of strain MRSA ATCC 43300 was prepared in saline and a 10-fold dilution series carried 104 out. CFU/ml was determined by spread plating each dilution on CBA in and incubating at 105 37°C for 24 h. 106
To calculate the LoD of the assay when MRSA suspensions were used directly for 107 DNA extraction protocols.40 µl of each dilution above was added to 260 µl of buffer Q-108 LYS supplied in the GQM kit. Subsequent extraction of these 300 µl preparations, PCR 109 and ELISA based detection were performed as per the manufacturers' instructions. 110
To calculate the LoD when MRSA suspensions were absorbed onto Copan 111 screening swabs prior to DNA extraction 100 µl of each dilution above was adsorbed 112 onto an individual swab. The swab was allowed to dry for 30 min before vigorous 113 vortexing in 300 µl of buffer Q-LYS and GQM processing. 114
Using the CFU/ml count determined above, the LoD of each reaction was 115 determined, and the equivalent CFU/ml was calculated. LoD were recorded as the lowest 116 concentration which produced a GQM assay positive reaction. 117 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 follows. Swabs that were PCR positive, culture negative were cultured a second time, but 144 were enriched overnight in 5 ml of tryptone salt broth 6% NaCl (37°C at 150 rpm in a 145 shaking incubator) with subsequent plating on CA. Specimens that were PCR negative, 146 culture positive were processed again by PCR i.e. as per manufacturer's instruction 5 µl 147 of the 300 µl extracted specimens were tested a second time by GQM PCR. Additionally, 148 the MRSA isolate recovered from the discrepant specimen was tested by PCR in pure 149 culture as per manufacturer's instructions. 150
151

Results
152
Analytical sensitivity and specificity 153
The GQM assay detected all MRSA strains in a collection representative of 154
MRSA in Ireland since 1974 (n=32). All eight MRCNS tested negative. Of seven 155
GrMSSA strains tested, 3 tested positive by PCR and are considered false positives. 156
157
LoD assays 158
Using a saline dilution series and plate counting, the LoD when MRSA 159 suspensions were used directly for DNA extraction and subsequent GQM amplification 160 was determined to be 704 CFU/GQM reaction (equivalent to a calculated 1.7x10 4 161 CFU/ml). As only 5 µl of the extracted 300 µl DNA preparations can be used as template 162 in the GQM PCR reaction, it can be said the LoD per PCR is 11.8 CFU. 163 In a GQM reaction where a swab was washed in GQM buffer Q-LYS containing a 169 known number of MRSA cells, the lowest number of MRSA detected was 1,390 170 CFU/reaction. In contrast, where the swab was first rubbed on a CA plate and then 171 washed in GQM buffer Q-LYS containing the same number of MRSA cells as above, the 172 lowest number of MRSA detected was 5,560 CFU/reaction, suggesting processing of 173 swabs on CA prior to GQM PCR does have an inhibitory effect and increases LoD per 174 reaction or CFU/ml by a factor of 4 (approximately). 175
Clinical specimens 177
Of 540 specimens processed 47/540 (8.7%) were both PCR and culture positive 178 and 451/540 (83.5%) were negative by both methods. Discrepant results occurred with 179 42/540 (7.7%) specimens; 4 were PCR positive but culture negative and 38 were PCR 180 negative but culture positive. All four patients with a positive PCR and culture negative 181 result had been decolonised and thus were considered true MRSA positives. The 182 amended MRSA positive rate was therefore calculated as 51/540 (9.4%), with a 183 discrepant rate of 38/540 (7.0%). For these remaining 38 discrepant results (PCR 184 negative/culture positive specimens), PCR rechecks of the prepared DNA extracted/lysis 185 reactions were carried out and all were confirmed negative. 186 All 38 swabs were plated a second time on CA and subsequently enriched in TSB 187 broth for 24 h followed by plating on CA. Twelve grew after direct plating and 188 enrichment, suggesting the microorganisms were present on the swabs but were not 189 detected by PCR. PCR on all 12 of these isolates (colony tested) were PCR positive, 190 therefore these were considered true PCR false negatives. S. aureus was not isolated 191 again after repeat culture with enrichment in TSB for the remaining 26/38 discrepant 192 specimens. These were considered false negatives. The sensitivity, specificity, positive 193 predicative value (PPV) and negative predictive value (NPV) were calculated ( The LoD of GQM can be reported in a number of ways. Here we established the 209 LoD of the complete GQM assay to be 704 CFU. This is the minimum number of MRSA 210 cells required to be added to the GQM extraction mix that will result in a positive 211 hybridization signal. LoD can also be expressed as LoD per PCR and has this has been 212 calculated as 11.8 CFU per PCR. As many studies report LoD of rapid assays in CFU per 213 ml or CFU per swab these GQM LoD results can also be reported as 1.4x10 4 CFU/ml or 214 1.7 x10 3 CFU/swab. By contrast, the LoD of other rapid methods have been reported as 215 6.1 x10 2 CFU/ml or 5.8 x10 1 CFU/swab for GeneXpert and 1.7x10 2 CFU/swab for 216 routine MRSA chromogenic culture [4] . 217
Processing clinical specimens on CA and subsequent GQM amplification as 218 described here results in a discrepant rate of 7% (38 specimens were PCR negative, 219 culture positive). Twelve of the 38 discrepant specimens reported as PCR negative/ 220 culture positive, were culture positive both prior to GQM processing and when cultured a 221 second time after discharge in the Q-LYS lysis buffer, suggesting that these were false 222 negatives by GQM. 223
However, 26/38 specimens that were culture positive/PCR negative were not 224 found to be culture positive after a second attempt to culture them following discharge in 225 the GQM buffer Q-LYS solution. Some possible explanations for these discrepancies 226 include: (i) discrepancy due to this workflow i.e. processing by culture before GQM 227 removed all organisms from the swab hence a GQM negative result (ii) PCR inhibition 228 resulted from rubbing the swab on a CA plate prior to GQM processing (iii) the lysis 229 reaction may have failed or may not have been optimal but there is no control for this 230 reaction when using the GQM kit and (iv) these 26 specimens were not detected as GQM 231 F o r P e e r R e v i e w 11 positive because inoculum levels were below the LoD of the GQM assay. Depending on 232 the interpretation of these findings various sensitivities could be calculated. If we 233 excluded the 26 specimens from sensitivity calculations that were GQM negative, culture 234 positive from the analysis, assuming that because of the work flow used all organisms 235 had been removed by culture prior to PCR or CA inoculation resulted in inhibition, a 236 GQM sensitivity of 81% would be achieved. If we included the 26 specimens in the 237 sensitivity calculation but assumed that all 26 specimens would have been PCR 238 positive/culture positive if specimens had been processed by PCR first followed by 239 culture, then an improved sensitivity of 87% would result. However, the actual sensitivity 240 determined here was 57%. The true value for the sensitivity value is at best between 241 81%-87% but at worst between 57-81%, depending on the interpretation of the PCR 242 negative culture positive discrepant results. A full study to establish the diagnostic 243 sensitivity of Hain GQM would be valuable. 244
We acknowledge the limitations in our evaluation which include the number of 245 specimens tested, confining the testing to nasal and groin specimens only (other licensed 246 specimens include throat and wounds), the taking of only one specimen per site for both 247 PCR and culture and the processing of this specimen by culture prior to PCR instead of 248 vice-versa. While an evaluation of two swabs per site, i.e. one for PCR and one for 249 culture might have led to fewer discrepant results, this represents considerable additional 250 processing time and expense for routine diagnostic laboratories. Additionally, we did not 251 want to alter the accredited method of culture as this was an evaluation in a routine 252 diagnostic setting, thus minimizing any deviations from normal practice was important. 253
Furthermore, discrepancies may still have occurred if two specimens had been taken, e.g. 254 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 In summary, while agreement of results occurred for 92.3% of specimens 258 processed with culture first followed by PCR, the number of discrepant results, and 259 questions posed by these results suggest that culture followed by PCR using the one swab 260
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is not suitable for routine use. It is unclear if an alternative swab processing regime, i.e. 261 PCR followed by culture would overcome these shortcomings but this may result in a 262 reduced yield from culture. Consequently it is likely that where both culture and PCR are 263 being used, two swabs need to be taken with the resulting time and expense incurred. 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
